Jan Phillip W.
- Country
- Germany
- Department
- NA
Research Overview
Data & Insights
Has run more than one trial at 31 of 124 partner sites.
Specializations
Hematologic Oncology
The investigator specializes in treating diffuse large B-cell lymphoma (DLBCL), focusing on innovative therapeutic approaches in lymphoid malignancies.
- B-cell lymphoma management
- Antibody-drug conjugate therapies
- Combination treatment strategies
Research interests include evaluating novel therapeutic agents and their integration with established treatment protocols for aggressive lymphomas.
Immunotherapy Research
Expertise in targeted immunotherapy approaches for hematologic malignancies, with particular attention to antibody-based treatments.
- Novel antibody conjugates
- Immunotherapeutic strategies
- Response assessment methods
The investigator focuses on developing and evaluating new immunotherapeutic options for lymphoma patients.
Clinical Assessment
Specialized in response evaluation criteria in lymphoma treatment, utilizing advanced assessment methodologies.
- Lugano response criteria
- Treatment efficacy evaluation
- Comparative therapeutic analysis
Emphasis on precise evaluation of treatment outcomes in lymphoma therapy using standardized assessment criteria.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.